You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

3-Period Crossover

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

OSA, Obstructive Sleep Apnea Trial in Los Angeles, Boston, Saint Louis (Period A, Period B, Period C)

Not yet recruiting
  • OSA
  • Obstructive Sleep Apnea
  • Period A
  • +2 more
  • Los Angeles, California
  • +2 more
Mar 30, 2023

Obstructive Sleep Apnea Trial in Cincinnati (AD182, AD504, Placebo)

Completed
  • Obstructive Sleep Apnea
  • Cincinnati, Ohio
    Intrepid research, LLC
Aug 16, 2022

Hypertension, Diabetes, Type 2 Trial in Incheon (BR1019-1, BR1019-2, BR1019-1 + BR1019-2)

Recruiting
  • Hypertension
  • Diabetes Mellitus, Type 2
  • Incheon, Korea, Republic of
    Inha University Hospital
May 16, 2023

Healthy Trial in New Haven (PF-06821497 Treatment A, PF-06821497 Treatment B, PF-06821497 Treatment C)

Not yet recruiting
  • Healthy
  • PF-06821497 Treatment A
  • +5 more
  • New Haven, Connecticut
    New Haven Clinical Research Unit
Mar 17, 2023

Pharmacokinetics, Bioavailability Trial in Nottingham (Sorafenib - Period 1, XS005 Sorafenib Capsule A - Period 1, XS005

Completed
  • Pharmacokinetics
  • Bioavailability
  • Sorafenib - Period 1
  • +8 more
  • Nottingham, United Kingdom
    Quotient Sciences
Jul 20, 2023

Healthy Trial (HC-ER + 40% Alcohol, HC-ER + 20% Alcohol, HC-ER + 0% Alcohol)

Completed
  • Healthy
  • HC-ER + 40% Alcohol
  • +2 more
  • (no location specified)
Nov 8, 2022

Healthy Trial in Tempe (Danicopan: Powder-In-Capsule 1, Danicopan: Powder-In-Capsule 2, Danicopan: Tablet)

Completed
  • Healthy
  • Danicopan: Powder-In-Capsule 1
  • +2 more
  • Tempe, Arizona
    Clinical Trial Site
Apr 8, 2022

Healthy Trial in Tempe (Darigabat)

Completed
  • Healthy
  • Tempe, Arizona
    Celerion Inc.
Jan 20, 2022

Sleep Apnea Trial in Adelaide (Danavorexton, Placebo)

Recruiting
  • Sleep Apnea
  • Adelaide, Australia
    Adelaide Institute for Sleep Health (AISH), Flinders University
May 11, 2022

Hypertension, Hyperlipidemia (E.G., Hypercholesterolemia) Trial in Incheon (BR1018-1, BR1018-2)

Recruiting
  • Hypertension
  • Hyperlipidemia (E.G., Hypercholesterolemia)
  • Incheon, Korea, Republic of
    Inha University Hospital
Jul 13, 2022

Healthy Trial in Lincoln (ALXN1840, Omeprazole)

Completed
  • Healthy
  • Lincoln, Nebraska
    Clinical Trial Site
Apr 1, 2022

Healthy Trial (Dexamethasone, Chronocort: fasted, Immediate release hydrocortisone: fasted)

Completed
Has Results
  • Healthy
  • (no location specified)
Apr 5, 2022

Healthy Adult Subjects Trial in Tempe (Omaveloxolone, Efavirenz)

Not yet recruiting
  • Healthy Adult Subjects
  • Tempe, Arizona
    Celerion, Inc.
Jun 16, 2023

Allergic Rhinitis Trial in Austin (Ciclesonide)

Completed
Has Results
  • Allergic Rhinitis
  • Austin, Texas
    ALTANA Pharma
Mar 1, 2022

Healthy Trial in Lincoln (ALXN1840 Enteric-coated Tablet, ALXN1840 Non-coated Capsule, Omeprazole)

Completed
  • Healthy
  • ALXN1840 Enteric-coated Tablet
  • +2 more
  • Lincoln, Nebraska
    Clinical Trial Site
Apr 1, 2022

Asthma Trial in London, Manchester (TD-8236, Placebo)

Completed
Has Results
  • Asthma
  • London, United Kingdom
  • +1 more
Feb 17, 2022

Healthy Participants Trial in Hollywood (Dabigatran, PF-07321332/ritonavir + Dabigatran, Ritonavir + Dabigatran)

Completed
  • Healthy Participants
  • Hollywood, Florida
    Research Centers of America ( Hollywood )
Jan 18, 2022

Healthy Participants Trial in New Haven (PF-07284890 Treatment A, PF-07284890 Treatment B, PF-07284890 Treatment C)

Recruiting
  • Healthy Participants
  • PF-07284890 Treatment A
  • +2 more
  • New Haven, Connecticut
    New Haven Clinical Research Unit
Jun 28, 2022

Perennial Allergic Rhinitis, Rhinitis, Allergic Trial in Mississauga (Treatment A, Treatment B, Treatment C)

Completed
  • Perennial Allergic Rhinitis
  • Rhinitis, Allergic
  • Treatment A
  • +2 more
  • Mississauga, Canada
    Cliantha Research
Apr 6, 2022

Melanoma, BRAF V600 Mutation, Unresectable Melanoma Trial in Rennes (Binimetinib Oral Tablet)

Completed
  • Melanoma
  • +3 more
  • Binimetinib Oral Tablet
  • Rennes, France
    Biotrial
Mar 31, 2023

Relapsed or Refractory Lymphoma Trial in Austin (HMPL-523, Itraconazole, Rifampin)

Active, not recruiting
  • Relapsed or Refractory Lymphoma
  • Austin, Texas
    PPD Austin
Jan 31, 2023

Healthy Participants Trial in Brussels (Midazolam, PF-07321332/ritonavir + Midazolam, Ritonavir + Midazolam)

Completed
  • Healthy Participants
  • Brussels, Bruxelles-capitale, Région DE, Belgium
    Brussels Clinical Research Unit
Jan 18, 2022

Healthy Subjects Trial in London (HTL0016878.HCl Solution 10 mg, HTL0016878.Citrate Capsule 10 mg)

Completed
  • Healthy Subjects
  • HTL0016878.HCl Solution 10 mg
  • HTL0016878.Citrate Capsule 10 mg
  • London, United Kingdom
    Hammersmith Medicines Research Ltd (HMR)
Nov 1, 2021

Metastatic Melanoma, Unresectable Melanoma, Melanoma Trial (Lifileucel plus Pembrolizumab, Pembrolizumab with Optional Crossover

Not yet recruiting
  • Metastatic Melanoma
  • +2 more
  • Lifileucel plus Pembrolizumab
  • Pembrolizumab with Optional Crossover Period
  • (no location specified)
Feb 13, 2023

Healthy Subject Trial in Fargo (SACT-1, EDURANT 25Mg Tablet)

Completed
  • Healthy Subject
  • Fargo, North Dakota
    Novum Pharmaceutical Research Services
May 22, 2022